Title: APOLLO trial | TTR amyloidosis (FAP) clinical trial of patisiran from Alnylam
Description: APOLLO: An Alnylam clinical trial evaluating an investigational RNAi therapy for TTR amyloidosis patients with familial amyloidotic polyneuropathy (FAP)